Evolving burden of metabolic dysfunction–associated steatotic liver disease and its complications in a US nationwide healthcare system
The burden of MASLD-related cirrhosis and HCC is growing. While the burden of liver complications is similar between MASLD and ALD, the substantially larger size of the MASLD population means that the modest increases in incidence of cirrhosis and HCC could translate into a large absolute burden.
Authors
- Yumei Cao
- Roxanne Desiderio
- Jennifer R. Kramer (ORCID: https://orcid.org/0000-0003-2953-4949)
- Basim Ali (ORCID: https://orcid.org/0000-0002-4833-307X)
- Fasiha Kanwal (ORCID: https://orcid.org/0000-0002-1012-8767)
- Hashem B. El-Serag
- S Asch
- Xian Yu
- George Cholankeril
- Liang Li
- Ronald Samuel
Institutions
- Michael E. DeBakey VA Medical Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Baylor College of Medicine (US)
- Center for Innovation (US)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1097/hc9.0000000000000878
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00